Articles

  • 2 weeks ago | news.bloombergtax.com | Cassandre Coyer |Jeff Harrington |Catalina Camia

    The consumer privacy ombudsman tasked with analyzing the impact of 23andMe’s bankruptcy sale on individuals’ privacy has called for users’ consent before the sale of the company’s vast trove of genetic data receives court approval. Neil M. Richards told the bankruptcy judge that he couldn’t “conclude with certainty” that the sale of millions of customers’ genetic data is consistent with 23andMe’s privacy policy and statements.

  • 2 weeks ago | news.bloombergtax.com | Cassandre Coyer |Jeff Harrington |Catalina Camia

    Companies are at risk of losing a longtime partnership with the federal government in the fight against cyber criminals who wield stolen and fake identities to commit fraud, infiltrate business networks, and divert funds. President Donald J. Trump’s June 6 cybersecurity executive order ignored decade-old efforts to strengthen digital identity verification and stripped away more recent agency directions given by President Joe Biden.

  • 3 weeks ago | news.bloombergtax.com | Andrew Ramonas |Jeff Harrington |Catalina Camia

    The SEC can keep 2020 rules that activist investors say stop some environmental, social and governance proposals from getting votes at companies’ annual meetings, a federal judge ruled Thursday. The Securities and Exchange Commission acted appropriately when it adopted the shareholder proposal submission standards aimed at small investors during the first Trump administration, Judge Reggie B. Walton of the US District Court for the District of Columbia said in an opinion.

  • 1 month ago | news.bloombergtax.com | Jeff Harrington |Catalina Camia

    Target Corp., facing financial headwinds and pushback over its diversity, equity, and inclusion initiatives, has dismissed two executives who have backed DEI efforts, including a chief legal and compliance officer it hired nine months ago.

  • 1 month ago | news.bloombergtax.com | Cassandre Coyer |Catalina Camia |Jeff Harrington |David Jolly

    A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor. The May 19 announcement that Regeneron Pharmaceuticals Inc. will buy most of the assets of the bankrupt genetic testing provider started a countdown for Washington University School of Law professor Neil Richards, the court-appointed privacy ombudsman, to investigate the company’s privacy policies.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →